Metabolomics in the field of Oncology / Cancer Metabolomics


Metabolomics cancer research is being used to discover diagnostic cancer biomarkers in the clinic and in a research institute, to a better understand its complex heterogeneous nature, to discover pathways which involved in cancer that could be used for new targets and to monitor metabolic biomarkers during therapeutic intervention. These metabolomics approaches may also provide evidence to personalized cancer treatments by providing useful information to the clinician about the cancer patient’s response to medical interventions. The ultimate aims of most metabolomics cancer studies are to discover cancer-specific diagnostic, prognostic or predictive biomarkers for a patient. Untargeted metabolomics is an important and excellent tool for probing cancer-altered biochemical pathways.


    Related Conference of Metabolomics in the field of Oncology / Cancer Metabolomics

    May 04-05, 2026

    7th International Conference on Drug Chemistry

    Paris, France
    September 03-04, 2026

    16th World Glycobiology Congress

    Aix-en-Provence, France
    September 21-22, 2026

    24th International Conference on Structural Biology

    A Coruna, Spain

    Metabolomics in the field of Oncology / Cancer Metabolomics Conference Speakers